Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID05215353

Music Therapy vs. Cognitive-Behavioral Therapy for Cancer-related Anxiety (MELODY)

Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-05-22

368

Participants Needed

3

Research Sites

N/A

Total Duration

On this page

Sponsors

M

Memorial Sloan Kettering Cancer Center

Lead Sponsor

P

Patient-Centered Outcomes Research Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating how music therapy and cognitive behavioral therapy (CBT), both delivered virtually, may reduce anxiety in people who have survived cancer. This study also aims to understand if factors like age, sex, race, education, and expectations about therapy affect how well participants respond to these treatments. The trial is a Phase 4 study comparing these two non-drug therapies for cancer-related anxiety. Participants will be randomly assigned to receive either music therapy or cognitive behavioral therapy. Both treatments consist of seven weekly 60-minute group sessions conducted through a secure online platform (Zoom). Music therapy sessions involve personalized musical experiences guided by certified music therapists, including relaxation and musical engagement activities. CBT sessions focus on the connection between thoughts, behaviors, and emotions, led by licensed mental health providers. The study also includes a subgroup completing optional interviews and follows all participants for 26 weeks. Before randomization and at several points up to 26 weeks, participants will complete assessments measuring anxiety using the Hospital Anxiety and Depression Scale (HADS). Researchers will track changes in anxiety scores at 8 and 26 weeks. Participants must have access to Zoom and a private location for sessions. Safety and adherence are monitored throughout, with the study sponsored by Memorial Sloan Kettering Cancer Center.

CONDITIONS

Brief Title

A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • English- or Spanish-speaking
  • 18 years or older
  • Prior cancer diagnosis of any type or stage
  • Free of oncological disease, or stable disease with no evidence of progression
  • Score of 68 on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS)
  • Report anxiety symptoms lasting at least one month
  • Willing to adhere to all study-related procedures, including randomization to one of two treatment arms: MT or CBT
  • Access to Zoom and a quiet/private location
  • For advanced cancer sub-study: advanced cancer diagnosis, currently receiving oncological treatment or on active surveillance, Karnofsky performance score of 60, greater than 6-month expected survival as judged by oncologist
  • For group MT sub-study: English-speaking, prior cancer diagnosis, free of oncological disease or stable disease, score of 68 on HADS anxiety subscale, anxiety symptoms for at least one month, willing to adhere to procedures, access to Zoom and quiet/private location
Not Eligible

You will not qualify if you...

  • Completed active cancer treatment less than one month prior to enrollment (except maintenance hormonal or targeted therapies)
  • Active suicidal ideation, bipolar disorder, schizophrenia, or substance abuse
  • Score of 610 on the Blessed Orientation-Memory-Concentration test indicating cognitive impairment
  • Received seven or more MT or CBT sessions for anxiety within the last six months
  • Unable to provide informed consent
  • For advanced cancer sub-study: plan to receive psychotherapy in coming 8 weeks, recent or planned changes in anxiety medications
  • For group MT sub-study: prior receipt of MT within six months, plan for psychotherapy in coming 8 weeks, recent changes in anxiety medications

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (virtual)

Treatment

Duration - 7 weeks

Participants receive seven weekly 60-minute treatments of either music therapy or cognitive behavioral therapy, delivered virtually through Zoom.

7 weekly virtual visits

Follow-up

Duration - Up to 19 weeks after treatment

Participants complete study assessments at weeks 4, 8, 16, and 26 to monitor anxiety symptoms and treatment effects. A subgroup may participate in optional interviews after treatment.

Assessments at weeks 4, 8, 16, and 26; optional interviews after treatment

Trial Site Locations

Total: 3 locations

1

Baptist Alliance MCI

Miami, Florida, United States, 33143

Actively Recruiting

2

Memorial Sloan Kettering Cancer Center

New York, New York, United States, 10065

Actively Recruiting

3

Drexel University

Philadelphia, Pennsylvania, United States, 19104

Active, Not Recruiting

Loading map...

Research Team

J

Jun Mao, MD, MSCE

K

Kevin Liou, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Similar Trials

Efficacy of Advanced Radiotherapy in Gynecological Cancer Pa...

Gynecologic Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Music Therapy Versus Cognitive Behavioral Therapy via Telehealth for Anxiety in Survivors of Cancer: A Randomized Clinical Trial.

Kevin T Liou, Joke Bradt, M Beatriz Currier...

https://pubmed.ncbi.nlm.nih.gov/41494146